Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghiorzo

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
World Journal of Gastroenterology|August 21, 2015
Signs and genetics of rare cancer syndromes with gastroenterological featuresWilliam Bruno, Giuseppe Fornarini, Paola Ghiorzo
International Journal of Molecular Sciences|October 13, 2021
Insights into Mechanisms of Tumorigenesis in Neuroendocrine NeoplasmsLorenza Pastorino, Federica Grillo, Manuela Albertelli, et al.
Genes|January 23, 2024
Germline <i>POT1</i> Variants: A Critical Perspective on <i>POT1</i> Tumor Predisposition SyndromeVirginia Andreotti, Irene Vanni, Lorenza Pastorino, et al.
Annals of the Rheumatic Diseases|March 14, 2003
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritisM Cutolo, A Sulli, P Ghiorzo, et al.
Arthritis Research & Therapy|October 7, 2005
Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell lineMaurizio Cutolo, Silvia Capellino, Paola Montagna, et al.
Frontiers in Molecular Biosciences|July 23, 2020
The Current State of Molecular Testing in the BRAF-Mutated Melanoma LandscapeIrene Vanni, Enrica Teresa Tanda, Francesco Spagnolo, et al.
FEBS Letters|December 31, 1997
c-Rel and p65 subunits bind to an upstream NF-kappaB site in human granulocyte macrophage-colony stimulating factor promoter involved in phorbol ester response in 5637 cellsP Ghiorzo, M Musso, M Mantelli, et al.
Oncology Reports|August 30, 2017
TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclearPaola Monti, Paola Ghiorzo, Paola Menichini, et al.
Oncotargets and Therapy|February 6, 2015
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategiesFrancesco Spagnolo, Paola Ghiorzo, Laura Orgiano, et al.
Frontiers in Molecular Biosciences|August 8, 2020
Current State of Target Treatment in BRAF Mutated MelanomaEnrica Teresa Tanda, Irene Vanni, Andrea Boutros, et al.
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
World Journal of Gastroenterology|August 21, 2015
Signs and genetics of rare cancer syndromes with gastroenterological featuresWilliam Bruno, Giuseppe Fornarini, Paola Ghiorzo
International Journal of Molecular Sciences|October 13, 2021
Insights into Mechanisms of Tumorigenesis in Neuroendocrine NeoplasmsLorenza Pastorino, Federica Grillo, Manuela Albertelli, et al.
Genes|January 23, 2024
Germline <i>POT1</i> Variants: A Critical Perspective on <i>POT1</i> Tumor Predisposition SyndromeVirginia Andreotti, Irene Vanni, Lorenza Pastorino, et al.
Annals of the Rheumatic Diseases|March 14, 2003
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritisM Cutolo, A Sulli, P Ghiorzo, et al.
Arthritis Research & Therapy|October 7, 2005
Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell lineMaurizio Cutolo, Silvia Capellino, Paola Montagna, et al.
Frontiers in Molecular Biosciences|July 23, 2020
The Current State of Molecular Testing in the BRAF-Mutated Melanoma LandscapeIrene Vanni, Enrica Teresa Tanda, Francesco Spagnolo, et al.
FEBS Letters|December 31, 1997
c-Rel and p65 subunits bind to an upstream NF-kappaB site in human granulocyte macrophage-colony stimulating factor promoter involved in phorbol ester response in 5637 cellsP Ghiorzo, M Musso, M Mantelli, et al.
Oncology Reports|August 30, 2017
TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclearPaola Monti, Paola Ghiorzo, Paola Menichini, et al.
Oncotargets and Therapy|February 6, 2015
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategiesFrancesco Spagnolo, Paola Ghiorzo, Laura Orgiano, et al.
Frontiers in Molecular Biosciences|August 8, 2020
Current State of Target Treatment in BRAF Mutated MelanomaEnrica Teresa Tanda, Irene Vanni, Andrea Boutros, et al.
Pageof 15